Taiji Hamada

Kagoshima, 8908544, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Saturation Genome Editing Targeting KRAS Mutations in HCT 116 Colon Carcinoma Cells for Pooled SNV Functional Profiling in Diploid Cancer Model.

Saturation Genome Editing Targeting KRAS Mutations in HCT 116 Colon Carcinoma Cells for Pooled SNV Functional Profiling in Diploid Cancer Model.

Journal: Current issues in molecular biology

Published: February 25, 2026

MUC1 promoter methylation pattern diversity and its association with TET3 expression and prognosis in cholangiocarcinoma.

MUC1 promoter methylation pattern diversity and its association with TET3 expression and prognosis in cholangiocarcinoma.

Journal: Scientific reports

Published: May 10, 2025

Methylation heterogeneity of the AQP1 promoter as a candidate prognostic biomarker in cholangiocarcinoma.

Methylation heterogeneity of the AQP1 promoter as a candidate prognostic biomarker in cholangiocarcinoma.

Journal: Scientific reports

Published: April 12, 2025

Electroporation Induces Unexpected Alterations in Gene Expression: A Tip for Selection of Optimal Transfection Method.

Electroporation Induces Unexpected Alterations in Gene Expression: A Tip for Selection of Optimal Transfection Method.

Journal: Current issues in molecular biology

Published: December 30, 2024

Exercise Suppresses Head and Neck Squamous Cell Carcinoma Growth via Oncostatin M.

Exercise Suppresses Head and Neck Squamous Cell Carcinoma Growth via Oncostatin M.

Journal: Cancers

Published: February 23, 2024

Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma.

Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma.

Journal: Neuro-oncology advances

Published: September 25, 2023

Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma.

Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma.

Journal: Neuro-oncology advances

Published: August 02, 2023

MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.

MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.

Journal: BMC cancer

Published: January 31, 2023

Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines.

Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines.

Journal: International journal of molecular sciences

Published: November 19, 2022

Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma.

Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma.

Journal: Neuro-oncology advances

Published: August 01, 2022

Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic cancer.

Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic cancer.

Journal: Diagnostic cytopathology

Published: April 23, 2022

Esophageal plexiform fibromyxoma: A case report with molecular analysis for MALAT1-GLI1 fusion.

Esophageal plexiform fibromyxoma: A case report with molecular analysis for MALAT1-GLI1 fusion.

Journal: Pathology, research and practice

Published: February 25, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026